Clinical Trial: An Open-Label, Single-Arm, Phase II Clinical Study of Ivonescimab Combined with Chemoradiotherapy as Neoadjuvant Treatment for Limited-Stage Small Cell Lung Cancer (China)

Posted On: 2026-11-04

China, Nov. 4 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'An Open-Label, Single-Arm, Phase II Clinical Study of Ivonescimab Combined with Chemoradiotherapy as Neoadjuvant Treatment for Limited-Stage Small Cell Lung Cancer'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600135871

Registration Time: 2026/11/03

Type: Interventional study

Primary Sponsor: Cancer Hospital of Shandong First Medical University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=349316

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: An Open-Label, Single-Arm, Phase II Clinical Study of Ivonescimab Combined with Chemoradiotherapy as Neoadjuvant Treatment for Limited-Stage Small Cell Lung Cancer (China)